CD40 antibody
Quick Overview for CD40 antibody (ABIN1383854)
Target
See all CD40 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Specificity
- Recognises the Bp50 antigen, a 48 kDa protein
-
Purification
- Ion exchange chromatography
-
Sterility
- 0.22 μm filtered
-
Immunogen
- Raji cell line,Myeloma X63/AG.8653 x Balb/c spleen cells
-
Isotype
- IgG1 kappa
-
Biological Activity Comment
- Stimulates B-cell proliferation together with IL-4
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Phosphate-buffered saline. Sterile-filtered through 0.22 μm. Carrier and preservative free
-
Preservative
- Without preservative
-
Storage
- 4 °C
-
Storage Comment
- Stable at +2-8°C for 12 months. For longer storage freeze aliquots.
-
-
-
: "Differential effect of agonistic anti-CD40 on human mature and immature dendritic cells: the Janus face of anti-CD40." in: Blood, Vol. 106, Issue 8, pp. 2806-14, (2005) (PubMed).
: "In human B cells, IL-12 triggers a cascade of molecular events similar to Th1 commitment." in: Blood, Vol. 102, Issue 12, pp. 4084-9, (2003) (PubMed).
: "Extracellular signal-regulated protein kinase signaling pathway negatively regulates the phenotypic and functional maturation of monocyte-derived human dendritic cells." in: Blood, Vol. 98, Issue 7, pp. 2175-82, (2001) (PubMed).
: "CD86 (B7-2) on human B cells. A functional role in proliferation and selective differentiation into IgE- and IgG4-producing cells." in: The Journal of biological chemistry, Vol. 272, Issue 25, pp. 15613-9, (1997) (PubMed).
-
: "Differential effect of agonistic anti-CD40 on human mature and immature dendritic cells: the Janus face of anti-CD40." in: Blood, Vol. 106, Issue 8, pp. 2806-14, (2005) (PubMed).
-
- CD40
-
Alternative Name
- CD40
-
Molecular Weight
- 48 kDa
-
Pathways
- NF-kappaB Signaling, Cellular Response to Molecule of Bacterial Origin, M Phase, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
Target
-